Address
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064
United States
Phone
Website
Sector
Recent investment activity
KANDO id: 37787
Funding rounds
Actual initial investment stage
Investment activity status
Active investor
Selected investments
Displaying 1 - 18 of 18| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Topera Inc | Acquisition Initial investment led the round USD 250,000,000 (USD 250,000,000) | ||||
|
|
ViroPharma Inc | Provider of life-saving medicines for life-threatening diseases. | Acquisition Initial investment led the round USD 495,000,000 (USD 495,000,000) | |||
|
|
CFR Pharmaceuticals | Acquisition Initial investment led the round (USD 2,900,000,000) | ||||
|
|
IDEV Technologies Inc | Developer of next generation medical devices for use in the interventional radiology, vascular surgery, and cardiology device marketplace. | Acquisition Initial investment led the round USD 310,000,000 (USD 310,000,000) | |||
|
OptiMedica Corp | Acquisition Initial investment led the round USD 400,000,000 (USD 400,000,000) | ||||
|
|
Cardiac Concepts Inc | Now known as Respicardia Inc | Series C Initial investment | |||
|
|
Facet Biotech | Acquisition Initial investment USD 450,000,000 (USD 450,000,000) | ||||
|
|
Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | Acquisition Initial investment USD 400,000,000 (USD 400,000,000) | |||
|
|
Solvay Pharmaceuticals | Acquisition Initial investment led the round USD 6,600,000,000 (USD 6,600,000,000) | ||||
|
|
Evalve | Acquisition Initial investment led the round USD 410,000,000 (USD 410,000,000) | ||||
|
|
Evalve Inc | Acquisition Initial investment 410,000,000 (USD 410,000,000) | ||||
|
|
Ibis Biosciences | Acquisition Initial investment led the round USD 215,000,000 (USD 215,000,000) | ||||
|
|
Integrated Vascular Systems Inc | Medical device company developing devices to treat congestive heart failure. | Acquisition Initial investment | |||
|
|
Spinal Concepts Inc | Designer of spinal fixation technology for the medical industry (implants). | Acquisition Initial investment 170,000,000 (USD 170,000,000) | |||
|
|
Perclose Inc | Acquisition Initial investment USD 680,000,000 (USD 680,000,000) | ||||
|
|
Triangle Pharmaceuticals Inc | Anti-viral and oncology licensing company. | N/A Initial investment | |||
|
|
Icagen Inc | Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. | N/A Initial investment | |||
|
|
Hydra Biosciences Inc | N/A Initial investment |
Team
| Employee | Position | ||
|---|---|---|---|
| Miles White | N/A
Responsibilities: Executive Officer |
